Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Senior Advocate Diya Kapur, representing the petitioner, informed the court that some gyms were promoting these drugs as a ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

The plea alleged that licences for these drugs were given without appropriate scientific trials, data or noted potential ...

Delhi High Court asks DCGI to consult experts on weight-loss drug combinations, addressing concerns over safety and approval ...

The proceedings follow a PIL seeking a ban on sale of weight loss drugs that are still undergoing clinical trials ...

The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...

The Court instructed the DCGI to consult medical experts, stakeholders, and drug manufacturers before arriving at any regulatory decision. The bench of Justice Devendra Kumar Upadhyay and Justice ...

The Delhi High Court on Tuesday disposed of a public interest litigation (PIL) raising alarm over the off-label and ...

Weight loss medications containing liraglutide could provide significant relief for millions of migraine sufferers, according ...

Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key ...

The Delhi High Court on Wednesday directed the Central Drugs Standard Control Organisation (CDSCO) to decide, within 3 months ...